| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/29/2002 | US20020119942 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/29/2002 | US20020119940 Gene expression and delivery systems and uses |
| 08/29/2002 | US20020119926 Inhibitors of IAPP fibril formation and uses thereof |
| 08/29/2002 | US20020119921 Thrombospondin-2 and uses thereof |
| 08/29/2002 | US20020119919 Nucleic acids, proteins, and antibodies |
| 08/29/2002 | US20020119571 Stimulating lymphocytes of graft recipient by cells of graft donor or by cells expressing dominant Major Histocompatability Complex-molecules while transduced with immunmodulatory genes using gene transfer; prevents rejection of allogeneic grafts |
| 08/29/2002 | US20020119566 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
| 08/29/2002 | US20020119562 Method for selecting improved vectors |
| 08/29/2002 | US20020119554 Arginase II |
| 08/29/2002 | US20020119552 Human oncogene induced secreted protein I |
| 08/29/2002 | US20020119521 Expression vector or use as tools in gene therapy |
| 08/29/2002 | US20020119520 Polypeptide for use in the screening of bactericides and preventing infections |
| 08/29/2002 | US20020119519 Nucleotide sequences coding preferential polyeptide for use in the treatment of cancer, kidney and respiratory disorders |
| 08/29/2002 | US20020119517 Detection of modulators of body weight; obtain cell samples, monitor expression of preferenial genes, incubate with modulators, compare to control, monitor adjustment in body weight |
| 08/29/2002 | US20020119510 Enzymatic polypeptide for use in screening bactericides |
| 08/29/2002 | US20020119158 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/29/2002 | US20020119148 ErbB4 antagonists |
| 08/29/2002 | US20020119137 Useful in treating metabolic disorders or disorders associated with changes in adipose tissue physiological function or mass |
| 08/29/2002 | US20020119135 For therapy of neurodegenerative diseases characterized by apoptosis, including Parkinson's disease and Alzheimer's disease; blood clots, which left untreated could result in stroke; autoimmune diseasesl; cancer |
| 08/29/2002 | US20020119130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2002 | US20020119128 Graft acceptance through manipulation of thymic regeneration |
| 08/29/2002 | US20020119127 Method and system for optimizing minigenes and peptides encoded thereby |
| 08/29/2002 | US20020119126 Culturing adipose stromal cells in a medium capable of supporting the growth of fibroblasts and differentiation inducing amounts of beta - glycerophosphate and ascorbic acid and/or ascorbic-2 phosphate |
| 08/29/2002 | US20020119117 Modulated release particles for aerosol delivery |
| 08/29/2002 | CA2473197A1 Novel human protease and polynucleotides encoding the same |
| 08/29/2002 | CA2438775A1 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | CA2438769A1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/29/2002 | CA2438750A1 Aminoglycoside treatment for lysosomal storage diseases |
| 08/29/2002 | CA2438740A1 Drug metabolizing enzymes |
| 08/29/2002 | CA2438518A1 Method of treating neurological diseases |
| 08/29/2002 | CA2438322A1 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates |
| 08/29/2002 | CA2438235A1 Neurotransmission-associated proteins |
| 08/29/2002 | CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/29/2002 | CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/28/2002 | EP1234879A2 Human nucleic acid sequences from prostate tumour tissue |
| 08/28/2002 | EP1234877A1 Cell proliferation inhibitory protein, polynucleotide, antisense polynucleotide to the polynucleotide, and cell proliferation inhibitors, cancer diagnostics, cancer remedies and compositions for gene therapy by using the same |
| 08/28/2002 | EP1234876A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 08/28/2002 | EP1234188A2 Protein kinase regulation |
| 08/28/2002 | EP1234048A2 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 08/28/2002 | EP1234047A1 Drug inducible system and use thereof |
| 08/28/2002 | EP1234044A2 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 08/28/2002 | EP1234043A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/28/2002 | EP1234040A2 Hbv sequences |
| 08/28/2002 | EP1234039A2 85kDa NEISSERIAL ANTIGEN |
| 08/28/2002 | EP1234037A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 08/28/2002 | EP1234034A1 Transfer compounds, the production and the use thereof |
| 08/28/2002 | EP1234030A2 18 human secreted proteins |
| 08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1234025A1 Human enzymes of the metalloprotease family |
| 08/28/2002 | EP1234024A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 08/28/2002 | EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233980A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 08/28/2002 | EP1233977A1 Interleukin-1 homologue, mat il-1h4 |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233958A1 Inhibitors of histone deacetylase |
| 08/28/2002 | EP1233791A2 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 08/28/2002 | EP1233782A2 Eliciting hcv-specific antibodies |
| 08/28/2002 | EP1233779A2 New uses of suppressive macrophage activation factors |
| 08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233765A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-$g(d) ACTIVITY |
| 08/28/2002 | EP1233671A1 Compositions and methods for drug delivery using amphiphile binding molecules |
| 08/28/2002 | EP1005374A4 Microparticles for delivery of nucleic acid |
| 08/28/2002 | CN1366062A Recombination carrier and treating composition used in insulin dependent diabetes gene curing |
| 08/27/2002 | US6441153 Human carboxypeptidases and polynucleotides encoding the same |
| 08/27/2002 | US6441137 Tie-2 ligands; tie= ?tyrosine kinase with ig (immunoglobulins) and egf (epidermal growth factor) homology domains?; tumor neovascularization |
| 08/27/2002 | US6441135 Bak binding protein, DNA encoding the protein, and methods of use thereof |
| 08/27/2002 | US6440945 Enhancing blood perfusion ion by administering a dna encoding an angiogenic peptide; vascular endothelial growth factor (vegf) |
| 08/27/2002 | US6440944 Methods of administering adenoviral vectors |
| 08/27/2002 | US6440943 Mimic and/or modulate the activity of wild-type nucleic acids; the 5' and the 3'-terminal internucleoside linkages are chirally sp and internal internucleoside linkages are chirally rp; resistant to nuclease degradation; psoriasis |
| 08/27/2002 | US6440743 Supplying immobilizated polynucleotides |
| 08/27/2002 | US6440742 Recombinant AAV vector-based transduction system and use of same |
| 08/27/2002 | US6440737 Antisense modulation of cellular apoptosis susceptibility gene expression |
| 08/27/2002 | US6440732 Checkpoint/repair genes involved with dna repair prior to replication; aging resistance; cancer therapy |
| 08/27/2002 | US6440730 Retroviral hybrid vectors pseudotyped with LCMV |
| 08/27/2002 | US6440726 Gene therapy; cardiovascular diseases; for stimulating the formation, maturation or regression of blood vessels |
| 08/27/2002 | US6440701 Transferrin receptor genes of Moraxella |
| 08/27/2002 | US6440699 Prostate cancer susceptible CA7 CG04 gene |
| 08/27/2002 | US6440663 Renal cancer associated antigens and uses therefor |
| 08/27/2002 | US6440426 Antigen-containing formulation and methods of use thereof |
| 08/27/2002 | US6440422 Expressing foreign genes inserted at site of naturally occurring deletion in modified vaccinia virus ankara genome; polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy; encoding antigens as vaccines |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/27/2002 | US6440393 Sdministering aerosolized drug in an air mixture containing up to about 10% carbon dioxide gas for increasing the deposition of aerosolized drug in the respiratory tract of an individual or animal |
| 08/22/2002 | WO2002064838A2 Amplified cancer gene wip1 |
| 08/22/2002 | WO2002064832A1 Method of examining allergic disease |
| 08/22/2002 | WO2002064827A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | WO2002064805A2 Replication competent non-mammalian retroviral vectors |
| 08/22/2002 | WO2002064799A2 Optimized messenger rna |
| 08/22/2002 | WO2002064798A1 Dna sequences differentially expressed in tumour cell lines |
| 08/22/2002 | WO2002064790A2 Jfy1 protein induces rapid apoptosis |
| 08/22/2002 | WO2002064788A2 Compositions and methods relating to lung specific genes and proteins |
| 08/22/2002 | WO2002064781A2 Regulation of amyloid precursor protein expression by modification of abc transporter expression or activity |
| 08/22/2002 | WO2002064780A1 Dna sequences for human tumour suppressor genes |
| 08/22/2002 | WO2002064776A2 Signal transduction proteins 15b3, 15b3-1 and 15b3-2, and related dna sequences |
| 08/22/2002 | WO2002064775A1 Identification of genes involved in the tumourigenic process |
| 08/22/2002 | WO2002064771A1 Novel cell adhesion molecule specific to activated leukocyte |
| 08/22/2002 | WO2002064766A2 Bax-responsive genes for drug target identification in yeast and fungi |
| 08/22/2002 | WO2002064757A2 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/22/2002 | WO2002064755A2 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064746A2 Combined transductional and transcriptional targeting system for improved gene delivery |